import CountryWebPageSchema from "../../components/CountryWebPageSchema";
import Breadcrumbs from "../../components/Breadcrumbs";
import Link from "next/link";
import type { Metadata } from "next";

export const metadata: Metadata = {
  title: "Canada IVF Regulations & Fertility Law 2026 | FertilityCareHub",
  description:
    "Structured analysis of IVF regulations, donor laws, surrogacy policy, and fertility access rules in Canada. Updated regulatory insights for intended parents.",
  alternates: {
    canonical: "https://fertilitycarehub.com/countries/canada",
  },
  openGraph: {
    title: "Canada IVF Regulations & Fertility Law 2026",
    description:
      "In-depth fertility law analysis covering IVF, donor gametes, surrogacy, and access regulations in Canada.",
    url: "https://fertilitycarehub.com/countries/canada",
    siteName: "FertilityCareHub",
    type: "article",
  },
};
export default function CanadaPage() {
  return (
    <main className="min-h-screen bg-[#F5F1E8] text-[#1A1A1A]">
      <Breadcrumbs
  items={[
    { name: "Home", href: "/" },
    { name: "Countries", href: "/countries" },
    { name: "Canada", href: "/countries/canada" },
  ]}
/>
<CountryWebPageSchema
  countryName="Canada"
  countrySlug="canada"
  title="Canada: Fertility Jurisdiction Assessment"
  description="Strategic jurisdiction assessment and regulatory clarity for fertility care pathways within Canada."
/>
      {/* Top utility bar */}
      <div className="max-w-6xl mx-auto px-6 pt-10">
        <div className="flex items-center justify-between">
          <Link
            href="/countries"
            className="text-sm tracking-wide text-[#6A6256] hover:text-[#1A1A1A]"
          >
            ← Back to countries
          </Link>

          <Link
            href="/consultation"
            className="inline-flex items-center justify-center rounded-full border border-[#B89B5E] px-5 py-2 text-sm tracking-wide text-[#1A1A1A] hover:bg-[#F0E7D6]"
          >
            Review Canada Strategy Privately
          </Link>
        </div>
      </div>

      {/* Hero */}
      <section className="max-w-6xl mx-auto px-6 pt-14 pb-10">
        <div className="text-center">
          <div className="text-xs tracking-[0.28em] text-[#6A6256]">
            STRATEGIC ADVISORY DOSSIER
          </div>

          <h1 className="mt-5 text-5xl md:text-6xl leading-tight font-medium">
            Canada
          </h1>

          <p className="mt-6 max-w-3xl mx-auto text-lg leading-relaxed text-[#2A2A2A]">
            Canada is a governance-forward fertility market inside a clearly bounded ethical and
            regulatory environment. The strategic advantage is trust — strict constraints, strong
            clinical standards, and a predictable care culture. The tradeoff is that certain pathways
            are deliberately limited by law and policy. This dossier outlines when Canada is the right
            strategic fit and how to approach it with precision.
          </p>
        </div>
      </section>

      {/* Two-column decision block */}
      <section className="max-w-6xl mx-auto px-6 pb-10">
        <div className="grid md:grid-cols-2 gap-6">
          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h2 className="text-xl font-medium">When Canada is the right choice</h2>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                You want a <strong>high-trust</strong> market with a conservative ethical framework.
              </li>
              <li>
                Governance and transparency matter more than maximum pathway flexibility.
              </li>
              <li>
                You prefer a structured process, clear patient communication, and stable clinical operations.
              </li>
              <li>
                You value predictable post-treatment follow-up and continuity of care.
              </li>
              <li>
                You want an “inside-the-system” approach with low reputational and regulatory risk.
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h2 className="text-xl font-medium">When it’s not</h2>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                You require pathways that are restricted by Canada’s intentionally bounded framework.
              </li>
              <li>
                You want the fastest timelines without variability (wait times can differ by province and clinic).
              </li>
              <li>
                You are optimizing purely for lowest cost (Canada is not a low-cost medical tourism market).
              </li>
              <li>
                You want a highly commercial marketplace model; Canada is deliberately not that.
              </li>
            </ul>
          </div>
        </div>
      </section>

      {/* Framework */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
          <h2 className="text-2xl font-medium">Advisor framework: how to evaluate Canada</h2>

          <div className="mt-6 grid md:grid-cols-3 gap-6">
            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">GOVERNANCE</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                Canada’s strength is a bounded, ethics-forward system. The strategic question is
                whether those constraints align with your pathway needs.
              </p>
            </div>

            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">CLINIC MODEL</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                We evaluate operations: lab stability, monitoring cadence, written planning, and how
                the clinic handles complexity — not just brand recognition.
              </p>
            </div>

            <div>
              <div className="text-xs tracking-[0.25em] text-[#6A6256]">EXECUTION</div>
              <p className="mt-3 text-[15px] leading-relaxed text-[#2A2A2A]">
                Canada works best when you treat your pathway like a structured plan: documentation,
                timing, travel cadence (if any), and follow-up mapped in advance.
              </p>
            </div>
          </div>
        </div>
      </section>

      {/* Core sections */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="grid md:grid-cols-2 gap-6">
          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Ethical boundaries (strategic implication)</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                Canada’s system is designed to reduce commercial exploitation and protect patient interests.
              </li>
              <li>
                Some pathways are constrained by design; clarity is a feature, not a bug.
              </li>
              <li>
                We map what the framework permits, what it restricts, and what your alternatives are.
              </li>
            </ul>
            <p className="mt-5 text-sm text-[#6A6256]">
              Note: the right market is the one that aligns with your pathway and risk profile.
            </p>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Cost structure (strategic view)</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                Canada is typically a mid-to-premium market; it is not chosen primarily for low cost.
              </li>
              <li>
                The correct evaluation is total cost: cycle + lab add-ons + meds/monitoring + storage + logistics.
              </li>
              <li>
                We avoid public price tables; advisory provides bounded ranges and decision logic.
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Logistics and travel (including accommodation)</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                Many clients prefer Canada for continuity and calm logistics.
              </li>
              <li>
                If travel is required, we include <strong>accommodation</strong> as part of execution:
                2–3 vetted options chosen for comfort and predictability.
              </li>
              <li>
                The priority is reducing friction during treatment — not optimizing for “cheap stays.”
              </li>
            </ul>
          </div>

          <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
            <h3 className="text-xl font-medium">Clinic selection approach</h3>
            <ul className="mt-5 space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>
                We shortlist selectively (typically 4–5), not exhaustively.
              </li>
              <li>
                We prioritize lab stability, protocol clarity, and predictable communication cadence.
              </li>
              <li>
                We structure the decision around your constraints, not generic “rankings.”
              </li>
            </ul>
          </div>
        </div>
      </section>

      {/* What we exclude */}
      <section className="max-w-6xl mx-auto px-6 pb-12">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-8">
          <h3 className="text-xl font-medium">What we deliberately exclude (the private filter)</h3>
          <div className="mt-5 grid md:grid-cols-2 gap-6">
            <ul className="space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>Exhaustive clinic directories.</li>
              <li>Hotel price comparison grids.</li>
              <li>Generic claims without pathway fit analysis.</li>
            </ul>
            <ul className="space-y-3 text-[15px] leading-relaxed text-[#2A2A2A] list-disc pl-5">
              <li>Static pricing tables without verification.</li>
              <li>DIY bureaucracy playbooks (we coordinate with trusted partners).</li>
              <li>One-size-fits-all templates.</li>
            </ul>
          </div>
        </div>
      </section>

      {/* CTA */}
      <section className="max-w-6xl mx-auto px-6 pb-16">
        <div className="rounded-2xl border border-[#E5DDC8] bg-[#FAF7F1] p-10 text-center">
          <h3 className="text-2xl font-medium">Private advisory, not a public database.</h3>
          <p className="mt-4 max-w-2xl mx-auto text-[15px] leading-relaxed text-[#2A2A2A]">
            If Canada is on your shortlist, the decisive step is aligning your pathway to the right clinic model
            inside a bounded ethical framework — then mapping execution into a calm, predictable plan.
          </p>

          <div className="mt-7 flex items-center justify-center">
            <Link
              href="/consultation"
              className="inline-flex items-center justify-center rounded-full border border-[#B89B5E] px-6 py-3 text-sm tracking-wide text-[#1A1A1A] hover:bg-[#F0E7D6]"
            >
              Request Private Advisory Review
            </Link>
          </div>

          <div className="mt-3 text-xs tracking-wide text-[#6A6256]">
            Discreet, structured guidance aligned to your profile and jurisdictional constraints.
          </div>
        </div>
      </section>
      {/* Comparison guide CTA */}
<section className="mt-10 border border-[#E5DDC8] bg-white/60 rounded-xl p-5">
  <h3 className="text-lg font-medium">Compare destinations before choosing</h3>
  <p className="mt-2 text-sm text-[#6A6256] leading-relaxed">
    Use our structured framework to compare governance, donor pathway, eligibility friction,
    timeline realism, and execution risk across countries.
  </p>
  <Link
    href="/how-to-compare-fertility-jurisdictions"
    className="inline-block mt-3 underline text-sm"
  >
    Read the comparison guide →
  </Link>
</section>
      <section className="mt-16 border-t border-[#E5DDC8] pt-10">
  <h2 className="text-2xl font-semibold mb-6">Compare Other Jurisdictions</h2>
  <div className="grid grid-cols-1 md:grid-cols-3 gap-6">
    <Link href="/countries/united-states" className="border border-[#E5DDC8] p-6 rounded-xl hover:border-[#B89B5E] transition">
      <h3 className="text-lg font-medium">United States</h3>
      <p className="text-sm text-[#6A6256] mt-2">Premium capability and breadth for complex planning scenarios.</p>
    </Link>
    <Link href="/countries/united-kingdom" className="border border-[#E5DDC8] p-6 rounded-xl hover:border-[#B89B5E] transition">
      <h3 className="text-lg font-medium">United Kingdom</h3>
      <p className="text-sm text-[#6A6256] mt-2">Governance-first HFEA environment when oversight is key.</p>
    </Link>
    <Link href="/countries/spain" className="border border-[#E5DDC8] p-6 rounded-xl hover:border-[#B89B5E] transition">
      <h3 className="text-lg font-medium">Spain</h3>
      <p className="text-sm text-[#6A6256] mt-2">EU option with mature execution and strong donor pathway depth.</p>
    </Link>
  </div>
</section>
    </main>
  );
}
